Literature DB >> 10205774

Cardiovascular and metabolic responses to intermittent umbilical cord occlusion in the preterm ovine fetus.

L R Green1, J Homan, S E White, B S Richardson.   

Abstract

OBJECTIVE: To determine the cardiovascular and metabolic responses to umbilical cord occlusion in the preterm ovine fetus and the impact of repetitive intermittent insults over a 4-day period.
METHODS: Repetitive umbilical cord occlusions (experimental group, n = 7; control group, n = 7) were performed daily (112-115 days' gestation, term = 147 days). Mean arterial pressure (MAP), fetal heart rate (FHR), and FHR variation were monitored, and arterial blood was sampled at predetermined intervals.
RESULTS: During umbilical cord occlusions, arterial oxygen pressure (PaO2) (approximately 17 mmHg) and glucose (approximately 0.3) millimoles per liter (mmol/L) fell and arterial carbon dioxide pressure (approximately 8 mmHg) rose (P < .01) to a similar extent on days 1 and 4. Umbilical cord occlusion produced a rise in lactate over the course of successive umbilical cord occlusions each day, the magnitude of which tended to be reduced by day 4 (0.3 +/- 0.1 versus 0.6 +/- 0.1 mmol/L). Control hour FHR and MAP were unaltered over the 4 days, but the delta (delta) FHR to delta PaO2 ratio during umbilical cord occlusions was less on day 4 than on day 1 (6.0 +/- 0.4 versus 10.9 +/- 1.5 beats per minute/mmHg; P < .01). During occlusion hours, high FHR variation episodes, as a measure of fetal activity, were reduced (14.6 +/- 1.5 versus 4.2 +/- 1.3 min/h; P < .01), whereas the reduction in short-term (7.4 +/- 0.7 to 5.8 +/- 0.6 milliseconds; P < .05) and long-term (34.9 +/- 2.7 to 30.0 +/- 0.6 milliseconds; P < .05) FHR variation reached significance only on day 4.
CONCLUSION: The increase in lactate and reduced high-FHR variation episodes over successive umbilical cord occlusions may affect fetal growth and development. Furthermore, repeated umbilical cord occlusions over several days alter the preterm FHR response to subsequent stresses, suggesting an altered chemoreflex response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10205774     DOI: 10.1016/s1071-5576(98)00055-0

Source DB:  PubMed          Journal:  J Soc Gynecol Investig        ISSN: 1071-5576


  6 in total

1.  Adaptation of cardiovascular responses to repetitive umbilical cord occlusion in the late gestation ovine fetus.

Authors:  L R Green; Y Kawagoe; J Homan; S E White; B S Richardson
Journal:  J Physiol       Date:  2001-09-15       Impact factor: 5.182

Review 2.  The myths and physiology surrounding intrapartum decelerations: the critical role of the peripheral chemoreflex.

Authors:  Christopher A Lear; Robert Galinsky; Guido Wassink; Kyohei Yamaguchi; Joanne O Davidson; Jenny A Westgate; Laura Bennet; Alistair J Gunn
Journal:  J Physiol       Date:  2016-05-27       Impact factor: 5.182

3.  The impact of chronic intrauterine inflammation on the physiologic and neurodevelopmental consequences of intermittent umbilical cord occlusion in fetal sheep.

Authors:  Ilias Nitsos; John P Newnham; Sandra M Rees; Richard Harding; Timothy J M Moss
Journal:  Reprod Sci       Date:  2011-03-18       Impact factor: 3.060

4.  Monitoring fetal electrocortical activity during labour for predicting worsening acidemia: a prospective study in the ovine fetus near term.

Authors:  Martin G Frasch; Ashley E Keen; Robert Gagnon; Michael G Ross; Bryan S Richardson
Journal:  PLoS One       Date:  2011-07-15       Impact factor: 3.240

5.  Acceleration and deceleration capacity of fetal heart rate in an in-vivo sheep model.

Authors:  Massimo W Rivolta; Tamara Stampalija; Daniela Casati; Bryan S Richardson; Michael G Ross; Martin G Frasch; Axel Bauer; Enrico Ferrazzi; Roberto Sassi
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

6.  The impact of intermittent umbilical cord occlusions on the inflammatory response in pre-term fetal sheep.

Authors:  Andrew P Prout; Martin G Frasch; Ruud Veldhuizen; Rob Hammond; Brad Matushewski; Bryan S Richardson
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.